Compound 891
Identifiers
- Canonical SMILES:
Cc1cc(nn1-c1ccccc1C(=O)N1CCc2ccccc2C1)C(=O)N(c1ccccc1)c1ccccc1
- IUPAC name:
1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide
- InChi:
InChI=1S/C33H28N4O2/c1-24-22-30(33(39)36(27-14-4-2-5-15-27)28-16-6-3-7-17-28)34-37(24)31-19-11-10-18-29(31)32(38)35-21-20-25-12-8-9-13-26(25)23-35/h2-19,22H,20-21,23H2,1H3
- InChiKey:
GTQPMXUXXJDUHK-UHFFFAOYSA-N
External links
25181391 |
CHEMBL517577 |
24716934 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.10 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 512.22 g/mol | |||
HBA | 6 | |||
HBD | 0 | |||
HBA + HBD | 6 | |||
AlogP | 6.32 | |||
TPSA | 58.44 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
19027294 | 18 | BCL2 P10415 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 6.10 | |
19027294 | 18 | B2CL1 Q07817 |
|
Biochemical assay | Time-Resolved FRET | pKi (inhibition constant, -log10) | 4.91 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6071 | Apixaban | DB06605 | |
0.4768 | Alosetron | DB00969 | |
0.4656 | Rimonabant | DB06155 | |
0.4628 | Meclinertant | DB06455 | |
0.4570 | Surinabant | DB13070 | |
0.4534 | Danusertib | DB11778 | |
0.4524 | 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE | DB08527 | |
0.4389 | BMS-911543 | DB12591 | |
0.4389 | JHU-75528 C-11 | DB14902 | |
0.4378 | 1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole | DB04030 | |
0.4372 | (4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide | DB08137 | |
0.4363 | {[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide | DB08138 | |
0.4306 | Elacridar | DB04881 | |
0.4271 | Bentiromide | DB00522 | |
0.4260 | Nifenazone | DB13407 |